Literature DB >> 8575029

Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins.

K Tamaki1, K Tanzawa, S Kurihara, T Oikawa, S Monma, K Shimada, Y Sugimura.   

Abstract

To investigate a series of new inhibitors of gelatinases based on matlystatin B (1b), extensive structure-activity relationship studies were performed. The new derivatives were evaluated in vitro for the ability to inhibit gelatinases. The inhibitory activities against thermolysin were also assayed to test the compounds' selectivity. Among the compounds modified at the P'3 moiety, the N-methylamide derivative 5 g was virtually twice as effective on gelatinase B as the parent compound 1b (5g, IC50 = 0.27 microM vs. 1b, IC50 = 0.57 microM). Other derivatives, including 1) esters 7a and 7b having the ester portions P'2 and P'3, 2) the cyclic amino acids, L-proline or L-pipecolinic acid (13a and 13b) bearing P'2, and 3) compounds 29a and 29b representing an attachment of the pentyl side chain at C3' (P'1 side chain) instead of C2', all showed decreased potencies. The key discovery was the observation that the introduction of a nonyl group at the P'1 position yielded a compound (31f, IC50 = 0.0012 microM) with high inhibitory activity against gelatinases and high selectivity over thermolysin. This result suggested that the S'1 subsites of the gelatinases have a locally deep hydrophobic structure, since on the basis of the optimum inhibitory activity in the alkyl series, the nonyl group seems to fit best into this hydrophobic pocket. Thus 31f exhibited a 475-fold more potent inhibitory activity than 1b towards gelatinase B.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575029     DOI: 10.1248/cpb.43.1883

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

Authors:  G Bergers; R Brekken; G McMahon; T H Vu; T Itoh; K Tamaki; K Tanzawa; P Thorpe; S Itohara; Z Werb; D Hanahan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase.

Authors:  Lynn E Hancock; Marta Perego
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

3.  Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma.

Authors:  Divya Mehra; David I Sternberg; Yuxia Jia; Stephen Canfield; Vincent Lemaitre; Takwi Nkyimbeng; Julie Wilder; Joshua Sonett; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-25       Impact factor: 5.464

4.  Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice.

Authors:  N Igarashi; T Kubota; Y Otani; S W Matsuzaki; M Watanabe; T Teramoto; K Kumai; K Tamaki; K Tanzawa; T Kobayashi; M Kitajima
Journal:  Jpn J Cancer Res       Date:  1999-01

Review 5.  Challenges in Matrix Metalloproteinases Inhibition.

Authors:  Helena Laronha; Inês Carpinteiro; Jaime Portugal; Ana Azul; Mário Polido; Krasimira T Petrova; Madalena Salema-Oom; Jorge Caldeira
Journal:  Biomolecules       Date:  2020-05-05

6.  Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors.

Authors:  Franziska Leipoldt; Javier Santos-Aberturas; Dennis P Stegmann; Felix Wolf; Andreas Kulik; Rodney Lacret; Désirée Popadić; Daniela Keinhörster; Norbert Kirchner; Paulina Bekiesch; Harald Gross; Andrew W Truman; Leonard Kaysser
Journal:  Nat Commun       Date:  2017-12-06       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.